Association of the factor XII 46C>T polymorphism with risk of coronary heart disease (CHD) in the WOSCOPS study
- 1 November 2002
- journal article
- clinical trial
- Published by Elsevier in Atherosclerosis
- Vol. 165 (1) , 153-158
- https://doi.org/10.1016/s0021-9150(02)00196-x
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Fibrinolytic Activation Markers Predict Myocardial Infarction in the ElderlyArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- An Enzyme-Linked Immunosorbent Assay (ELISA) for the Measurement of Activated Factor XII (Hageman Factor) in Human PlasmaJournal of Immunoassay, 1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- Alterations of Coagulation and Fibrinolytic and Kallikrein-Kinin Systems in the Acute and Postacute Phases in Patients With Unstable Angina PectorisCirculation, 1995
- Hageman factor and risk of myocardial infarction in middle-aged menAtherosclerosis, 1992
- Long-lasting depression of the factor XII-dependent fibrinolytic system in patients with myocardial infarction undergoing thrombolytic therapy with recombinant tissue-type plasminogen activator: A randomized placebo-controlled studyJournal of the American College of Cardiology, 1991
- The scanning model for translation: an update.The Journal of cell biology, 1989
- Mechanisms of activation of the classical pathway of complement by Hageman factor fragment.Journal of Clinical Investigation, 1983
- A comparision of the abilities of plasma kallikrein, β-factor XIIa, factor XIa and urokinase to activate plasminogenThrombosis Research, 1983
- Activation of Human Factor VII in Plasma and in Purified SystemsJournal of Clinical Investigation, 1979